S
keletal muscle homeostasis is maintained by the equilibrium of physical and functional interactions between myofibres and different cell types that compose the muscle environment, including muscle (satellite) stem cells (MuSCs), motoneurons and a variety of interstitial cells, such as vessel-associated cells, fibroblasts, PW1-expressing interstitial cells (PICs) and fibro-adipogenic progenitors (FAPs) [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Environmental perturbations trigger dynamic alterations in cell type composition and the functional interactions between these cells to activate a compensatory response towards restoring the original homeostasis. For instance, in response to acute injury, a timely coordinated appearance of the inflammatory infiltrate and the expansion of interstitial cells instruct MuSCs to regenerate the damaged muscle [5] [6] [7] . However, in conditions of chronic injury, loss of coordination between these cell types results in maladaptive fibrosis and ectopic fat deposition, as observed during the progression of muscular dystrophies 2, 8 . Among interstitial cells, FAPs are emerging as key effectors of compensatory or maladaptive repair of injured muscles [9] [10] [11] . In unperturbed skeletal muscles, FAPs are present in a steady state; however, they rapidly expand in response to muscle injury 9, 10 . FAPs accumulation is preceded by the appearance of the inflammatory infiltrate and is followed by MuSC activation [12] [13] [14] [15] . This temporal pattern suggests a key role for FAPs in converting inflammatory cues into pro-regenerative signals. FAP expansion and activation are also restricted within a precise window of time by signals derived from the inflammatory infiltrate 14, 15 . Impaired FAP clearance leads to their abnormal accumulation and the formation of fibrotic scars and fat deposition, which inhibit muscle regeneration [16] [17] [18] . It is currently unknown whether environmental perturbations that do not activate an inflammatory response, such as muscle denervation, can stimulate FAP expansion and eventually promote functional properties different from those reported in injured muscles.
Results
Abnormal accumulation of FAPs during muscle atrophy by acute denervation. We compared the temporal kinetics of the appearance of macrophages (MPs), FAPs and MuSCs in skeletal muscles subjected to either acute injury (by cardiotoxin) or denervation (by sciatic nerve transection), which trigger two opposite responses. A transient deposition of collagen (Fig. 1a-d and Supplementary  Fig. 1a ) and reduction of myofibre calibre (Fig. 1e ) during the first seven days post acute injury were typically followed by a prompt resolution of fibrotic infiltration (Fig. 1a-d and Supplementary  Fig. 1a ) and recovery of myofibre size (Fig. 1e) . By contrast, muscle denervation-induced progressive accumulation of fibrosis ( Fig. 1a-d and Supplementary Fig. 1a ) and reduction of the myofibre cross-sectional area (CSA) (Fig. 1e) . These opposite responses reflect the differential ability of injured muscles to regenerate, as
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Articles NATure CeLL BIOLOGy compared to denervated muscles, with embryonal-myosin heavy chain (eMyHC)-positive regenerating fibres observed in acutely injured muscles, but not in denervated muscles ( Supplementary  Fig. 1b) . Fluorescence-activated cell sorting (FACS) ( Fig. 1f and Supplementary Fig. 1c ) and immunofluorescence ( Supplementary  Fig. 2a-f ) analyses showed that, although coordinated dynamics of MP, FAP and MuSC activation were observed in response to acute injury, a progressive accumulation of FAPs was detected in denervated muscles, in the absence of any significant increase in MP and MuSC number. Of note, we found higher 5-ethynyl-2'-deoxyuridine (EdU) incorporation in CD90-positive interstitial cells (another FAP marker) 10 from denervated muscles, as compared to unperturbed controls ( Supplementary Fig. 1d ). This indicates that FAPs can be activated in response to different perturbations and within distinct cellular and functional contexts, and suggests the possibility that FAPs' activities could also differ depending on the type of perturbation.
FAPs from denervated muscles exhibit distinct functional properties and gene expression profiles. We next investigated the functional differences between FAPs isolated from injured (FAP CTX) or denervated (FAP DEN) muscles. FAPs isolated from regenerating muscle post injury typically enhance skeletal myoblast fusion into multinucleated myotubes 9, 10, 16, 18 . We exploited the transwell co-culture system to determine whether FAPs from denervated muscles could exert similar or different effects on skeletal myoblasts. FAPs isolated from regenerating muscles (at day 3 post-acute injury) could significantly increase the formation of multinucleated myotubes from co-cultured myoblasts, but FAPs from denervated muscles (isolated at day 15 post denervation) showed much reduced Values represent mean ± s.d. **P < 0.01, *P < 0.05, one-way ANOVA (n = 12 CTR; n = 20 DEN15d; n = 6 DEN3d, CTX7d; n = 4 CTX3d, CTX15d; n = 3 DEN7d, DEN30d, CTX30d; n refers to animal numbers).
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NATure CeLL BIOLOGy ability to enhance myoblast fusion into myotubes (Fig. 2a,b) . Because FAP activation following denervation coincides with the progressive muscle atrophy caused by loss of integrity of neuromuscular junctions (NMJs), we evaluated the potential contribution of FAP DEN to muscle atrophy, by measuring the changes in calibre of preformed myotubes following transwell co-culture with FAP DEN, as compared to FAP CTX or controls (that is, myotubes co-cultured with FAPs from unperturbed muscles-FAP NT-or without any co-cultured cells). Only co-culture with FAP DEN caused a drastic reduction of myotubes calibre (Fig. 2c,d ).
We next performed RNA-seq analysis of FAPs isolated from denervated muscles at two time points post denervation: 7 days (FAP DEN7d) and 15 days (FAP DEN15d). These transcriptional profiles were compared to those from RNA-seq analysis of FAP NT and FAP CTX (3 days post injury). Although FAP CTX showed extensive patterns of gene up-and downregulation compared to FAP NT, FAP DEN exhibited a significantly smaller amount of differentially expressed (DE) genes, with a trend towards a progressive increase in both up-and downregulated genes from day 7 to day 15 post denervation ( Supplementary Fig. 3a) . A heatmap representation of RNA-seq analysis revealed clear differences in the gene expression profiles of FAPs from these conditions (Fig. 2e) .
Principal component analysis (PCA) further demonstrated that FAP DEN (at both time points) clustered in the opposite direction to FAP CTX, with both PC1 and PC2 discriminating them (Fig. 2f) . A Venn diagram representation of common and unique gene expression profiles revealed the presence of a large amount of condition-specific as well as commonly expressed genes ( Fig. 2g and Supplementary Fig. 3b ). Functional annotation of biological differences predicted by ingenuity pathway analysis (IPA) revealed that commonly expressed genes included the cell identity surface markers, Sca1, PDGF-α receptor and CD90 9, 10 , which allow isolation of FAPs in experimental conditions, as well as genes implicated in migration and extracellular signalling and fibrosis ( Fig. 2g and Supplementary Fig. 3b) . Fibrosis is indeed a common outcome for both conditions, although it was transiently induced by CTX, but persisted upon denervation ( Supplementary Fig. 1a ). Among condition-specific DE genes, FAP CTX-specific gene expression was enriched in genes associated with cell proliferation, DNA synthesis, mitosis and cell cycle checkpoints, while FAP DEN-specific gene expression patterns were enriched in functional categories implicated in the activation of inflammatory processes that included potential soluble mediators of pro-atrophic and catabolic signalling ( Fig. 2g and Supplementary Fig. 3b ). Among them, the concurrent activation of signal transducer and activator of transcription 3 (STAT3) and interleukin-6 (IL-6), which have been reported to be functionally interconnected [19] [20] [21] [22] , stood out as the main activated pathway from both IPA ( Fig. 2g and Supplementary Fig. 3b ) and upstream regulator analysis (Table 1 ). Progressive and persistent activation of IL-6 gene expression was indeed detected by qPCR in FAP DEN at various time points following denervation, at variance with FAP CTX, which exhibited transient and less robust upregulation of IL-6 transcripts at day 7 post acute injury (Fig. 2h) . Enzyme-linked immunosorbent assay (ELISA) analysis of IL-6 concentrations in the supernatant from cultures with FAPs, MuSCs and MPs revealed that FAP DEN are the most abundant source of IL-6 secretion among these intramuscular cell populations (Fig. 2i) . Consistent with a potential paracrine activity of FAP-derived IL-6 in denervated muscles, we detected a progressive activation STAT3 in total lysates from denervated muscles (7 days post sciatic nerve section), while only a transient STAT3 activation was detected in regenerating muscles at 3 days post injury (Fig. 2j) .
Persistent activation of IL-6-STAT3 pathway in FAPs and myofibres from denervated muscles and prevention of myofibre atrophy and fibrosis by IL-6 blockade. Because muscles are composed of different cell types, we sought to further determine the identity of the cells in which STAT3 was activated, by their anatomical localization. Immunofluorescence of muscle sections from denervated (DEN) or unperturbed (CTR) mice showed that the phospho-STAT3 signal was predominantly localized in nuclei of cells within the muscle interstitial space as well as in the myonuclei of muscle fibres (Fig. 3a) . Western blot with protein extracts from FACSisolated FAPs showed that STAT3 signalling was robustly activated in FAP DEN, but not in MuSC DEN, consistent with a selective activation of STAT3 in FAPs by denervation. The phospho-STAT3 signal detected in the myonuclei (Fig. 3a) predicted an activation of the STAT3 pathway also in denervated myofibres. Indeed, immunofluorescence analysis of single fibres isolated from unperturbed (CTR) or DEN muscles showed the presence of phospho-STAT3 signal localized in the typical myonuclear position only in DEN fibres (Fig. 3c) . Accordingly, western blot analysis of the protein lysate from the same fibres confirmed STAT3 activation in DEN fibres (Fig. 3d) . RNA-seq analysis of single fibres from denervated muscles revealed extensive alterations in gene expression induced by denervation ( Supplementary Fig. 4a,b) , with an activation of IL-6-STAT3 signalling, among other putative effectors of muscle atrophy and adaptation ( Supplementary Fig. 4c -e) [23] [24] [25] . 
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As IL-6-STAT3 signalling has been implicated in skeletal muscle atrophy [19] [20] [21] [22] , we first determined whether incubation with neutralizing antibodies against IL-6 (anti-IL-6) could counter FAP DEN-induced atrophy of co-cultured myotubes. Figure 3e ,f shows that exposure to anti-IL-6 almost completely prevented the reduction of myotube calibre caused by co-culture with FAP DEN. Effects observed in co-culture systems typically entail the possibility that both or either co-cultured cell types are affected by the experimental conditions. For instance, anti-IL-6 can interrupt the IL-6-STAT3 feedforward loop in FAPs, thereby decreasing FAPderived IL-6; however, IL-6 has been also reported to directly promote muscle atrophy 22 . To determine whether anti-IL-6 selectively affects FAP-mediated myotube atrophy, we incubated supernatants from FAPs (supFAP) DEN or CTR with anti-IL-6, and observed an inhibition of the reduction in myotube calibre caused by DEN supFAP, as compared to CTR supFAPs (Fig. 3g,h ). We then evaluated whether systemic delivery of anti-IL-6 for 15 days could reduce myofibre atrophy following sciatic nerve transection in two-month-old mice. Anti-IL-6 treatment effectively prevented CSA reduction (Fig. 3i,j) and loss of weight (Fig. 3k ) in TA muscles of denervated mice. Of note, anti-IL-6 did not alter the increase in number of DEN FAPs (Fig. 3l) , although it could completely prevent STAT3 activation in whole muscle (Fig. 3m) , indicating an effective neutralization of FAP-derived IL-6 signalling, and suggesting that FAP expansion following denervation occurs independently on IL-6. Importantly, IL-6 blockade was also sufficient to prevent denervation-induced fibrosis (Fig. 3n,o) , another effect potentially induced by DEN FAPs. 
STAT3 inhibition in DEN FAPs
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NATure CeLL BIOLOGy reduction (Fig. 4a,b) and loss of weight (Fig. 4c) , as well as fibrosis (Fig. 4d ,e) in denervated muscles of mice subjected to sciatic nerve severing. STAT3i could also effectively prevent the reduction of myotube calibre following transwell co-culture with FAP DEN (Fig. 4f,g) ; however, when STAT3i was added to DEN supFAP before incubation with myotubes, it failed to prevent the myotube atrophy (Fig. 4h,i) , indicating that the anti-atrophic effect of systemic STAT3i delivery is accounted for by the inhibition of IL-6-STAT3 signalling in FAPs. Together with data shown in Fig. 3e- Supplementary Fig. 5a -e) or with Pax7 CRE mice ( Supplementary Fig. 5f,g ), respectively, did not prevent denervationinduced myofibre atrophy, further indicating that STAT3 activation in myofibres or MuSCs does not contribute to denervation-induced muscle atrophy.
To explore the specific contribution of FAP DEN IL-6-STAT3 signalling to myofibre atrophy in vivo, we tested whether FAP DEN could be sufficient to induce myofibre atrophy following their transplantation into skeletal muscles of wild-type (WT) mice. In one experimental approach, FAPs isolated from denervated muscles of GFP mice (GFP-FAP DEN) were incubated ex vivo for 3 h with STAT3i or vehicle (DMSO) and then injected into 
NATure CeLL BIOLOGy muscles of WT mice (Fig. 5a) . Transplantation of GFP-FAP DEN led to a significant reduction of CSA in myofibres of recipient muscle (Fig. 5a-c) ; however, when GFP-FAP DEN were exposed to STAT3i before transplantation, their pro-atrophic effect was prevented (Fig. 5a-d) . In another approach, freshly sorted FAP DEN from R26R
TdT Stat3 fl/fl transgenic mice (or R26R TdT Stat3 +/+ , as control) were infected with Cre-expressing adenovirus before transplantation into muscles of WT mice. Transplanted FAP DEN were visualized by TdT expression, and led to CSA reduction of fibres from recipient mice (Fig. 5e-g) ; however, this effect was not observed following genetic deletion of STAT3 (Fig. 5e-h ). Of note, we observed that transplanted muscles did not show features of interstitial fibrosis in these experimental conditions. Collectively, these data indicate that DEN FAPs acquire a cell-autonomous pro-atrophic potential that relies on activation of STAT3 signalling and IL-6 secretion, which are initially triggered by denervation, but persists even in the absence of denervation. By contrasts denervation-induced fibrosis appears to require the concomitant presence of muscle denervation, in addition to DEN FAPs.
Thus, selective inhibition of IL-6-STAT3 signalling in DEN FAPs is sufficient and necessary to counter muscle atrophy and fibrosis, presumably by interrupting a denervation-activated feedforward loop that leads to chronic secretion of abnormal levels of IL-6. Indeed, our evidence that STAT3 activation and IL-6 secretion are consensually inhibited in FAPs isolated from denervated muscles of mice treated with either anti-IL-6 or STAT3i ( Supplementary  Fig. 5h ) supports the existence of a reciprocal positive feedback between IL-6 and STAT3 cascades in DEN FAPs. The upregulation of IL-6 receptor observed in FAP DEN by RNA-seq (Table 1) probably propels this feedback.
FAPs with aberrant IL-6-STAT3 activation accumulate following loss of integrity of neuromuscular junctions.
The accumulation of FAPs in skeletal muscles following acute denervation suggests a previously unrecognized functional relationship between the integrity of NMJs and FAP activation. We therefore hypothesized that FAPs with an aberrant activation of IL-6-STAT3 could accumulate in conditions of acute traumatic damage of NMJs (for example, SCI) and/or progressive denervation, within physiological (aging) or pathological (for example, spinal muscle atrophy (SMA), amyotrophic lateral sclerosis (ALS)) conditions.
The dramatic reduction of the CSA (Fig. 6a) and induction of fibrosis (Fig. 6b,c) in muscles of four-month-old mice subjected to SCI coincided with an increased number of FAPs (Fig. 6d-f ) that exhibited deregulated activation of STAT3-IL-6 signalling and patterns of gene expression similar to those observed following sciatic nerve severing (Fig. 6g,h ). By contrast, the slowly 
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NATure CeLL BIOLOGy progressive and milder denervation occurring in aged (two years old) mice correlated with a proportionally milder reduction of CSA ( Supplementary Fig. 6a ) and fibrotic deposition ( Supplementary  Fig. 6b,c) , without increase in FAP number ( Supplementary Fig. 6d ) or expression of IL-6 and other genes typically induced by denervation ( Supplementary Fig. 6e ).
We next investigated the activation of FAPs by denervation within mouse models of two neuromuscular disorders, such as SMA and ALS. SMAΔ 7 is a mouse model of SMA, in which mice are born smaller (Supplementary Fig. 6f ) and with reduced muscle mass ( Supplementary Fig. 6g ), and typically die by the third week of age 26 . While the neonatal lethality and reduced muscle mass clearly limit the analysis of these animals and preclude a direct comparison with other models of denervation in adult mice, we could still observe a notable increase of FAPs relative to the reduced muscle mass of nine-day-old SMAΔ 7 mice (Supplementary Fig. 6h,i) . Moreover, FAPs isolated from nine-day-old SMAΔ 7 mice showed increased expression of IL-6 as well as other genes typically induced by denervation (Supplementary Fig. 6j ). Finally, we investigated the mouse model of ALS-SOD G93A mice. In these mice, a progressive reduction of CSA (Fig. 7a,c,d ) and loss of muscle weight (Fig. 7b) , concomitant with development of muscle fibrosis (Fig. 7e,f) , are typically observed within the first five months of life, with symptoms and signs manifesting between two and three months of life 27, 28 . We detected an increased number of FAPs in ALS muscles already at three months of life, leading to an accumulation that persisted throughout the disease progression (Fig. 7g) . However, only FAPs isolated from muscles of 140-day-old SOD G93A mice exhibited increased levels of IL-6 transcripts (Fig. 7h) and activated STAT3 signalling (Fig. 7i-j) , indicating a correlation between IL-6-STAT3 activation in FAPs and muscle atrophy and fibrosis at symptomatic stages of ALS, as also observed in ref.
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. We finally investigated whether the presence of FAPs in muscle biopsies of ALS patients could also discriminate pre-symptomatic from symptomatic stages of human disease progression. As Sca1 is not expressed in humans, and because of the inefficient detection of FAPs by anti-PDGFα receptor antibodies in human muscle sections, we used an alternative cell surface marker (CD90) 10 , which permits isolation of prospectively equivalent FAPs ( Supplementary  Fig. 7a,b) , to detect FAPs in muscles of ALS patients. Human ALS muscles showed reduction of CSA and fibrosis (Fig. 7k,l) and CD90-positive interstitial cells (Fig. 7m) at symptomatic stages of disease. We also detected an interstitial phospho-STAT3 signal (Fig. 7n) that coincided with CD90-positive cells ( Supplementary  Fig. 7c ). We therefore explored the potential ability of STAT3i to alleviate the consequence of FAP-derived pro-atrophic and fibrotic signalling in SOD G39A mice. The STAT3 inhibitor VI S3I-201 29 was administered systemically to eight-week-old SOD G39A mice until they reached 12 weeks of age. This treatment was sufficient to prevent muscle atrophy (Fig. 7o) and to reduce the formation of intramuscular fibrosis (Fig. 7p,q) .
Discussion
Our results revealed a previously unappreciated function of FAPs as source of pro-atrophic and pro-fibrotic signals in denervated muscles. Although the mechanism of FAP activation in denervated muscles remains unknown, we hypothesize that loss of NMJ could be a key trigger event. We initially reasoned that myofibre atrophy could promote FAP activation, by perturbing the spatial equilibrium between myofibres and the interstitial space. However, we could not observe any comparable accumulation of FAPs in other pro-atrophic conditions that spared the functional integrity of NMJ, such as forced immobilization by casting or hindlimb suspension. Consistently, the slowly progressive deterioration of NMJs that accompanies milder reduction in CSA of aged muscles did not coincide with a significant increase in FAP number and IL-6 expression.
By contrast, activation of FAPs with aberrantly activated IL-6-STAT3 signalling was invariably observed in all conditions of severe functional impairment of NMJs, irrespective of whether they were caused by acute trauma (SCI) or rapidly progressive neuromuscular disorders (SMA and ALS). Collectively, this evidence indicates that the degree of severity of denervation is a key determinant for FAPs to adopt a pro-atrophic and fibrotic phenotype. As chronic activation of IL-6-STAT3 is a distinctive feature of DEN FAPs and mediates these pathological outcomes, we argue that persistent rise of IL-6 from an intramuscular cellular source activated by denervation (for example, DEN FAPs) accounts for the severity of atrophy and fibrosis that was observed in these conditions. In this regard, it is likely that reciprocal positive feedback between IL-6 and STAT3 pathways sustain a feedforward circuit that propels the persistent activation of IL-6-STAT3 signalling in DEN FAPs, whereby FAPsecreted IL-6 activates STAT3 (and vice versa) in an autocrine manner. It is interesting to note that the potential paracrine effect of FAP-derived IL-6 on STAT3 activation in other neighbouring cells within denervated muscles appears restricted to myonuclei, at variance with the activation of STAT3 signalling that is typically observed in MuSCs following acute or chronic injury 29 . We argue that in denervated muscles the lack of infiltration by inflammatory cells (for example, macrophages) together with the integrity of the key anatomical component of MuSC niche (for example, the basal lamina) insulate MuSCs from environmental signals, such as FAPderived IL-6, thereby preventing an aberrant activation of STAT3 signalling in quiescent MuSCs.
Although a moderate increase of circulating IL-6 has been observed during aging 30 , abnormally elevated concentration of circulating IL-6 are found during cancer cachexia, which correlates with a rapid and dramatic loss of muscle mass 31 . Moreover, IL-6-STAT3 signalling can be activated by inflammation-free perturbations of skeletal muscle, such as contraction and hypertrophy 30, 32 , which lead to anabolic responses-the opposite biological outcome of denervation-induced muscle atrophy. Thus, differences in cellular sources and relative amounts of local or systemic IL-6, duration of activation of downstream (for example, STAT3) or parallel cascades, and co-stimulatory signals from the local milieu appear to determine the final biological effect of this IL-6 on muscles.
Finally, our work indicates that targeting IL-6-STAT3 signalling in DEN FAPs with FDA-approved drugs [33] [34] [35] could be used to counter muscle atrophy and fibrosis following acute denervation or during ALS progression.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0151-y.
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NATure CeLL BIOLOGy Methods Animals. All experiments in this study were performed in accordance with protocols approved by the Italian Ministry of Health, the National Institute of Health (IIS), the Santa Lucia Foundation (Rome) and by the Sanford Burnham Prebys Medical Discovery Institute Animal Care and Use Committee. The study is compliant with all relevant ethical regulations regarding animal research.
C57BL/6J and CD1 mice were provided by the Core Structure of the EMMA (European Mouse Mutant Archive) and by the SBP Animal Facility (La Jolla). Two-to three-month-old male mice were used for ex vivo experiments. The hemizygous transgenic mice carrying the mutant human SOD1 G93A (B6. Cg-Tg(SOD1*G93A)1Gur/J) gene were originally obtained from Jackson Laboratories. R26R TdT mice were purchased from Jackson Laboratories. Stat3 flox/flox were a gift from S. Akira (described in ref. 36 ). R26RTdT and Stat3 flox/flox mice were used to generate the R26R TdT Stat3 flox/flox mice and control R26R TdT STAT3 +/+ animals. Pax7CreERStat3 flox/flox mice were generated as described in ref. 29 .
MCKCreStat3
flox/flox were a gift from S. Schenk (described in ref. 37 ). The SMA mouse model used was FVB.Cg-Tg(SMN2*delta7) 4299Ahmb Tg(SMN2)89Ahmb Smn1tm1Msd/J (Jackson Laboratory), hereafter referred to as SMAΔ 7 mice. Genomic DNA was isolated from the tail, amplified by PCR using the primers listed below, and genotyped as described previously 26 . SMAΔ 7 mice were scarified at 8 days of postnatal life. Control littermates were used as controls (WT).
Denervation and muscle injury. Denervation was performed as previously described 38 . Briefly, unilateral hindlimb denervation was performed by transecting the sciatic nerve under anaesthesia by intraperitoneal injection of 40 mg kg −1 ketamine (Zoletil) and 10 mg kg −1 xylazine (Rampum). Following exposure of the sciatic nerve, a 0.5 cm piece was transected near to the head of the femur. The lesion was sutured after the operation.
Muscle injury was performed by intramuscular injection of 10 μ g ml
cardiotoxin (CTX, Latoxan). Tissues were harvested after 3, 7, 15 and 30 days for FACS or histological analyses.
STAT3 inhibitor and anti-IL-6 treatments.
Neutralization with IL-6 (1.0 mg ml ) was performed on denervated and SOD G93A mice. Denervated mice were treated for 15 days by intraperitoneal injection with Stat3i. Injection was performed every 3 days starting from day zero-the day on which denervation was performed. Similarly, SOD G93A mice were treated every 3 days starting from 8 weeks, for 4 weeks.
Tissue samples for cryosectioning were snap frozen in liquid-nitrogen-cooled isopentane and stored at − 80 °C until processing. Tissue samples for RNA/DNA were also cooled in liquid nitrogen.
Spinal cord injury. Three-month-old CD1 female mice (Charles River Laboratories or EMMA InfraFrontiers) were used in SCI. To perform SCI, mice were deeply anaesthetized with a mixture 1:1 of Rompun (Bayer 20 mg ml ), the back hairs were shaved, the skin was disinfected with betadine, and an incision was made to expose the spinal cord. Animals were mounted on a stereotaxic apparatus with spinal adaptors connected to a cortical PinPoint precision impactor device (Stoelting) and maintained at 37 °C throughout surgery. To induce a severe trauma the following parameters were set up: middle, round and flat tip (#4); velocity 3 m s -1 ; depth 5 mm; dwell time 800 ms. The impact was applied at the thoracic level (vertebrae T10-T11). Analysis of the graphical impact parameters, operated by the PinPoint software, was used to identify potential outliers. Behavioural analyses were also used to corroborate differences in injury severity within groups. Slight lesions were excluded from the study based on these criteria.
Cell preparation and FACS isolation. Hindlimb muscles were digested in PBS with 2 µ g ml −1 collagenase A (Roche), 2.4 U ml −1 Dispase I (Roche), 10 ng ml 
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. The FACS sorting gating strategy is provided in the Supplementary  Information (Supplementary Fig. 1c ).
FAP transplants. R26R
TdT STAT3 flox/flox mice and control R26R TdT STAT3 +/+ animals were denervated. At 15 days after denervation, FAPs were isolated by FACS as CD31− , CD45− , Ter− , α 7 integrin− and Sca1+ cells. After isolation, cells were plated overnight and infected with an adenovirus coding for the Cre recombinase (50000 MOIs (multiplicity of infection)). After infection, FAPs were resuspended in PBS and transplanted into the tibialis anterior of C57BL6/J host mice. 50,000 FAPs were transplanted into each muscle.
For studies with the STAT3 inhibitor (STAT3 inhibitor VI, S3I-201, CAS 501919-59-1 Calbiochem), we isolated FAPs from denervated EGFP mice (15 days after denervation). After isolation, FAPs were incubated for 3 h with the STAT3 inhibitor (100 μ M) (or with the vehicle, DMSO) at 4 °C with rotation. After treatment, 30,000 FAPs were transplanted into the tibialis anterior of C57BL6/J host mice.
Transplanted muscles from both experimental designs were collected 7 days after transplantation to perform histological analysis.
Histology immunofluorescence.
For the histological analysis, 8-10 µ m muscle cryosections were analysed. Both cryosections and cultured cells were fixed in 4% PFA for 10 min and permeabilized with 100% acetone for 1 min at room temperature (RT) or with 0.25% Triton for 15 min at RT. Muscle sections and cultured cells were then blocked for 1 h with a solution containing 4% BSA in PBS. PAX7 staining was performed by an antigen retrieval protocol. Primary antibodies immunostaining was performed O/N at 4 °C and then the antibody binding specificity was revealed using secondary antibodies coupled to Alexa Fluor 488, 594 or 647 (Invitrogen). Sections were incubated with DAPI in PBS for 5 min for nuclear staining, washed in PBS, and mounted with mounting medium or glycerol (3:1 in PBS).
The primary antibodies used for immunofluorescences are rabbit anti-Laminin (#L9393, Sigma, 1:400); mouse anti-Caveolin-3 (#610420, BD Transduction Laboratories; 1:1,000); rat anti-SCA1 (Ly-6A/E, eBioscence For H&E staining, sections were fixed in 4% PFA for 10 min, washed in PBS and then stained in haematoxylin for 8 min and eosin for 1 min. The muscle sections were further dried in gradually increasing concentration of ethanol/ water solutions and, after fixation in 100% xylene, were mounted with EUKITT mounting medium (Sigma-Aldrich). Sirius Red staining was performed to analyse total collagen I and III content. Muscle cryosections were fixed for an 1 h at 56 °C in Bouin's solution and then stained in Picro-Sirius Red (0.1%) solution for 1 h while protected from light. After a brief washing in acidified water 0.5% vol/vol, sections were fixed in 100% ethanol and the final dehydration was performed in xylene 100%. Sections were mounted with EUKITT and visualized using a Nikon Eclipse 90i.
Masson's trichrome staining was performed as described in ref. 16 . The transverse sections were visualized on a Zeiss confocal microscope or a Nikon Eclipse 90i fluorescent microscope and then edited using the ImageJ software. The figures reported are representative of all the examined fields.
Human samples. Muscle biopsies from ALS patients were obtained for diagnostic purposes in the Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. All patients signed informed consent to use the samples for research. After muscle was obtained from surgeon, the sample was frozen in isopentane cooled with liquid nitrogen. Muscle sections (5 μ m) were obtained using a cryostat CM1950 from Leica.
Morphometric analysis. Whole TA myofibre cross-sections were performed with staining for Laminin and quantified by ImageJ software. The values are shown as an average percentage of the frequency distribution.
Fibrotic areas were calculated from sections by evaluating image analysis algorithms for colour deconvolution. ImageJ was used for image processing; the original image was segmented with three clusters and the plugin assumes images generated by colour subtraction.
Proteins extraction and western blot. Total protein extract was obtained by homogenizing TA muscles with TissueRuptor (Qiagen) proteins lysis buffer (50 mM Tris-HCl pH 7.5, Sigma; 1 M NaCl, Sigma; 625 mM Saccarosio, Sigma; 10% Glicerolo, Sigma; 1% Triton x-100, Sigma) with protease and the phosphatase inhibitors 1 mM PMSF, Sigma; 2 g ml −1 aprotinin, Sigma;10 g ml
Leupeptin, Sigma; 10 g ml −1 Pepstatin, Sigma; 1 mM NaF, Sigma; 0.1 mM Na 3 VO 4 , Sigma). After separation with 8% SDS-PAGE gels, proteins were transferred to nitrocellulose membranes (Trans-Blot Turbo, Bio-Rad, 170-4158) and then blocked in a solution of 5% skim milk (Sigma) in TTBS, and incubated ON at 4 °C with primary antibodies. Western blot was performed using antibodies against the following proteins: STAT3 Tyr705 (#9131S, Cell Signaling, 1:1,000); STAT3 (#4904S, Cell Signaling, 1:1,000); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (#97166S, Cell Signaling, 1:1,000). The membranes were then incubated 1 h at RT with the corresponding secondary antibodies: goat polyclonal anti-rabbit (1:2,000 in T-TBS) or anti-mouse (1:1,000 in T-TBS) IgG antibody conjugated to horseradish peroxidase (HRP) (Santa Cruz). The signal was detected with a ChemiDoc MP Imaging System (Bio-Rad) and the protein expression levels were then quantified by ImageJ software and normalized on GAPDH.
RNA analysis by quantitative PCR. Total RNA from TA muscles was extracted using TRI Reagent (Sigma) following the manufacturer's protocol. The cell RNA was isolated with a Qiagen RNeasy mini-kit following the manufacturer's protocol. After quantification with a Nanodrop 8000 spectrophotometer, the isolated RNA was retrotranscribed using the TaqMan Reverse Transcription Reagents kit (Applied Biosystems). The cDNA was used as a template in real-time qPCR reactions, performed with SYBR green Master Mix reagents (Applied Biosystems) with an ABI PRISM 7000 sequence detection system, using primers as described in the Supplementary Information. Values were further normalized on GAPDH.
ELISA assay. ELISA essay was performed using 72 h conditioned medium (BIOAMF-2 or GM) from each population with mouse interleukin-6 (mouse IL-6) ELISA Kit (#KMC0061, Invitrogen).
Co-culture conditions of FAPs and C2C12. C2C12 and FAPs cells were cocultured using inserts with 1 μ m porous membrane to avoid direct contact between populations. For fusion index analysis, C2c12 were grown independently from FAPs in GM (DMEM w/o pyruvate with 2% FBS (Gibco)) for 72 h in 24-well culture plates (BD Bioscience). For myotube diameter analysis, C2c12 were grown independently from FAPs in GM for 72 h and for 72 h in DM (DMEM w/o pyruvate with 2% horse serum, Gibco) in 24-well culture plates. After C2C12 differentiation after 72 h of GM, freshly sorted FAPs cells were plated on the upper insert, and transwell co-cultures were maintained for an additional 72 h.
In the co-cultures experiment, treatment with anti-IL-6 was performed using aIL-6 neutralizing antibody (0.02 mg ml −1 LEAF purified anti-mouse IL-6, cat. no. 504506, BioLegend) for 72 h.
For Red oil staining, FAPs cells were inducted to differentiate in adipocites as described in ref. 16 .
Myofibre isolation. For myofibre isolation, muscle digestion was performed for 1 h at 37 °C with digestion buffer (DMEM + pyruvate, 0.4% collagenase from Clostridium hystoliticum (C6885)). The content of the digestion buffer was then poured in horse serum-coated dishes for direct isolation of myofibres at RT. Isolation of single myofibres was realized using a medium-sized pipette (re-equilibration of the medium was performed by incubation at 37 °C in 5% CO 2 for 5 min minimum). This passage was repeated at least three times to remove debris. The single myofibres were incubated at 37 °C in 5% CO 2 . Immunostaining on myofibres was performed on floating as described in refs 38, 39 . RNA-seq. FAPs were isolated from mice GA muscle as described in ref. 18 . RNA from FAPs was extracted using an RNeasy Mini kit (Qiagen) following the manufacturer's protocol. RNA was shipped to the sequencing IGA of Udine. The libraries for sequencing were prepared using NuGEN Ovation System V2 RNA-Seq. For each biological sample two independent experiments were carried out for the isolation of RNA. All duplicates are from different mice, sorted at different times.
RNA-seq data processing. For sequencing alignment we used the human reference genome assembly GRCm38/mm10 (http://ftp.ensembl.org/pub/release-76/fasta/ mus_musculus/dna/), and for transcriptome annotation we used version 85 of the GRCm38 (http://ftp.ensembl.org/pub/release85/gtf/mus_musculus/Mus_musculus. GRCm38.85.gtf.gz). We used the FASTQC package (v0.11.3) to assess the quality of sequenced libraries. All passed quality control. Reads were mapped to the reference genome using TopHat2 v.2.1.1. We used the following non-default TopHat2 parameters: -p 48 -g 1 --library-type fr-firststrand. The number of mapped reads ranged between 23 × 10 6 and 44 × 10 6 and the percentage of mapping was between 79 and 92%. The quality control of the reads distribution along transcripts was performed using infer_experiment.py from RSeQC package v2.6.3. All samples had a uniform distribution of reads along transcripts. The sequenced read counts per annotated gene were derived with the use of htseq-count script distributed with HTSeq v0.5.4p5. We used the R library package DESeq2 v.1.12.4 for measuring differential gene expression between two different cell conditions, considering the two RNA-seq experiments as biological replicates. We picked genes with adjusted P value < 0.01. Gene ontology analysis was performed using ingenuity pathway analysis (IPA; http://www.1ingenuity.com).
Primers sequences.
Genes Sequences Comparisons were made using the Student's t-test assuming a two-tailed distribution or by one-way ANOVA, with significance being defined as P < 0.05 (*), P < 0.01 (**) and P < 0.001 (***). Where appropriate and possible the exact P value is reported. The number of biological replicates for each experiment is indicated in the figure legends. RNA-seq data were obtained from two independent samples derived from different animals. 
